Bacterial Diseases

Published on 05/03/2015 by admin

Filed under Dermatology

Last modified 05/03/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 3005 times

61

Bacterial Diseases

Skin infection with bacteria may be a primary problem (e.g. impetigo) or a complication of another skin disease (e.g. atopic dermatitis). Nomenclature of these diseases often reflects the site and the depth of infection – that is, from the stratum corneum to the subcutaneous tissue (Fig. 61.1) – as well as the suspected causative organism.

Gram-Positive Cocci

Staphylococcal and Streptococcal Skin Infections

Streptococcal infections may be complicated by acute post-streptococcal glomerulonephritis; this occurs in <1% of patients in high-income countries, but it remains a significant problem in low-income countries.

Impetigo

Major organisms are Staphylococcus aureus and Streptococcus pyogenes (group A streptococci [GAS]).

A very common, highly contagious bacterial infection, most commonly seen on the face or extremities of children; usually the skin is eroded with overlying ‘honey-colored’ crusts, but there is a bullous variant (Fig. 61.2).

Interestingly, bullae formation due to S. aureus can be explained by local release of an exfoliative toxin that binds to desmoglein 1 and leads to dissolution (i.e. acantholysis) of the upper epidermis (see Chapter 23).

Risk factors for infection: nasal carriage of S. aureus and breaks in the epidermal barrier, e.g. atopic dermatitis, arthropod bites, trauma, scabies.

DDx of eroded lesions: insect bites, prurigo simplex, dermatitis (e.g. atopic, nummular), herpes simplex viral infection.

DDx of bullae: bullous insect bites, thermal burns, herpes simplex viral infection, and occasionally autoimmune bullous dermatoses.

Rx: local wound care (including soap), removal of crusts by soaking; for mild cases, topical mupirocin or retapamulin; for moderate to severe infections, oral antibiotics, the choice of which is dependent on prevalence of methicillin-resistant S. aureus (MRSA) in the local community (Table 61.1).